Evidence map›Paper›PMID 42359647›Full record

ArticleMolecular medicine reports2026

[Retracted] Puerarin promotes DUSP1 expression by regulating miR‑133a‑3p in breast cancer.

Zhifeng Li, Weiwei Xu, Xiaoyan Ren, Jinhua Xu, Jianxin Chen

Abstract readRetraction Notice
In one paragraph

Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Zhifeng LiDepartment of Breast Surgery, Nantong Maternity and Child Health Care Hospital Affiliated to Nantong University, Nantong, Jiangsu 226001, P.R. China.
Weiwei XuDepartment of Oncology, Nantong Tumour Hospital Affiliated to Nantong University, Nantong, Jiangsu 226001, P.R. China.
Xiaoyan RenDepartment of Pathology, Nantong Maternity and Child Health Care Hospital Affiliated to Nantong University, Nantong, Jiangsu 226001, P.R. China.
Jinhua XuDepartment of Traditional Chinese Medicine, Nantong Maternity and Child Health Care Hospital Affiliated to Nantong University, Nantong, Jiangsu 226001, P.R. China.
Jianxin ChenDepartment of Breast Surgery, Nantong Maternity and Child Health Care Hospital Affiliated to Nantong University, Nantong, Jiangsu 226001, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that the control β-actin blots shown in Fig. 3A on p. 209 had either appeared previously, or were subsequently to appear, in three other articles in different journals written by different authors at different research institutes. In addition, an independent analysis of the data in this paper undertaken by the Editorial Office revealed that the western blots for the Bax protein in Fig. 3A, the control β-actin blots in Fig. 4A and all the western blot data shown in Fig. 5A and C had also been included in five other papers written by different authors/research groups, the majority of which had already been published or were under consideration for publication when the above article was received at

Indexed as

breast cancerdual specificity phosphatase 1microRNA‑133a‑3ppuerarin

Identifiers

PMID42359647
PMCPMC13315670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.